326 related articles for article (PubMed ID: 34500564)
1. ST-2191, an Anellated Bismorpholino Derivative of Oxy-Fingolimod, Shows Selective S1P
Stepanovska Tanturovska B; Zivkovic A; Imeri F; Homann T; Kleuser B; Stark H; Huwiler A
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500564
[TBL] [Abstract][Full Text] [Related]
2. Morpholino Analogues of Fingolimod as Novel and Selective S1P
Stepanovska B; Zivkovic A; Enzmann G; Tietz S; Homann T; Kleuser B; Engelhardt B; Stark H; Huwiler A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899717
[TBL] [Abstract][Full Text] [Related]
3. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
Brinkmann V
Br J Pharmacol; 2009 Nov; 158(5):1173-82. PubMed ID: 19814729
[TBL] [Abstract][Full Text] [Related]
4. HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation.
Blaho VA; Galvani S; Engelbrecht E; Liu C; Swendeman SL; Kono M; Proia RL; Steinman L; Han MH; Hla T
Nature; 2015 Jul; 523(7560):342-6. PubMed ID: 26053123
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation.
Tsai HC; Han MH
Drugs; 2016 Jul; 76(11):1067-79. PubMed ID: 27318702
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine-1-phosphate and immune regulation: trafficking and beyond.
Chi H
Trends Pharmacol Sci; 2011 Jan; 32(1):16-24. PubMed ID: 21159389
[TBL] [Abstract][Full Text] [Related]
7. Selective Sphingosine 1-Phosphate Receptor 1 Agonist Is Protective Against Ischemia/Reperfusion in Mice.
Brait VH; Tarrasón G; Gavaldà A; Godessart N; Planas AM
Stroke; 2016 Dec; 47(12):3053-3056. PubMed ID: 27827329
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-phosphate (S1P) displays sustained S1P1 receptor agonism and signaling through S1P lyase-dependent receptor recycling.
Gatfield J; Monnier L; Studer R; Bolli MH; Steiner B; Nayler O
Cell Signal; 2014 Jul; 26(7):1576-88. PubMed ID: 24704119
[TBL] [Abstract][Full Text] [Related]
9. Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics.
Thangada S; Khanna KM; Blaho VA; Oo ML; Im DS; Guo C; Lefrancois L; Hla T
J Exp Med; 2010 Jul; 207(7):1475-83. PubMed ID: 20584883
[TBL] [Abstract][Full Text] [Related]
10. Novel compounds with dual S1P receptor agonist and histamine H
Imeri F; Stepanovska Tanturovska B; Zivkovic A; Enzmann G; Schwalm S; Pfeilschifter J; Homann T; Kleuser B; Engelhardt B; Stark H; Huwiler A
Neuropharmacology; 2021 Mar; 186():108464. PubMed ID: 33460688
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives.
Bravo GÁ; Cedeño RR; Casadevall MP; Ramió-Torrentà L
Cells; 2022 Jun; 11(13):. PubMed ID: 35805142
[TBL] [Abstract][Full Text] [Related]
12. AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis.
Samuvel DJ; Saxena N; Dhindsa JS; Singh AK; Gill GS; Grobelny DW; Singh I
PLoS One; 2015; 10(10):e0141781. PubMed ID: 26513477
[TBL] [Abstract][Full Text] [Related]
13. Role of the S1P pathway and inhibition by fingolimod in preventing hemorrhagic transformation after stroke.
Salas-Perdomo A; Miró-Mur F; Gallizioli M; Brait VH; Justicia C; Meissner A; Urra X; Chamorro A; Planas AM
Sci Rep; 2019 Jun; 9(1):8309. PubMed ID: 31165772
[TBL] [Abstract][Full Text] [Related]
14. Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation.
Garris CS; Wu L; Acharya S; Arac A; Blaho VA; Huang Y; Moon BS; Axtell RC; Ho PP; Steinberg GK; Lewis DB; Sobel RA; Han DK; Steinman L; Snyder MP; Hla T; Han MH
Nat Immunol; 2013 Nov; 14(11):1166-72. PubMed ID: 24076635
[TBL] [Abstract][Full Text] [Related]
15. [Effects of sphingosine 1-phosphate on functions of T cell - review].
Huang WR; Wang LS; DA WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):718-22. PubMed ID: 16129068
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling.
Mike EV; Makinde HM; Der E; Stock A; Gulinello M; Gadhvi GT; Winter DR; Cuda CM; Putterman C
Front Immunol; 2018; 9():2189. PubMed ID: 30319641
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension.
Meissner A; Miro F; Jiménez-Altayó F; Jurado A; Vila E; Planas AM
Cardiovasc Res; 2017 Feb; 113(2):123-133. PubMed ID: 28082452
[TBL] [Abstract][Full Text] [Related]
18. To fingolimod and beyond: The rich pipeline of drug candidates that target S1P signaling.
Chew WS; Wang W; Herr DR
Pharmacol Res; 2016 Nov; 113(Pt A):521-532. PubMed ID: 27663260
[TBL] [Abstract][Full Text] [Related]
19. Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis.
Mehling M; Johnson TA; Antel J; Kappos L; Bar-Or A
Neurology; 2011 Feb; 76(8 Suppl 3):S20-7. PubMed ID: 21339487
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-Induced and Stretch-Induced Sphingosine 1-Phosphate Production by Enthesis Cells Could Favor Abnormal Ossification in Spondyloarthritis.
El Jamal A; Briolay A; Mebarek S; Le Goff B; Blanchard F; Magne D; Brizuela L; Bougault C
J Bone Miner Res; 2019 Dec; 34(12):2264-2276. PubMed ID: 31373726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
